THE Pharmacy Board of Australia is reminding pharmacists that on 1 Oct, it will implement the revised guidelines on compounding of various medicines.
Published last month (PD 07 Aug), the Board's guidelines provide updated advice on when it is appropriate to compound medicines and introduced a new definition of 'commercial medicine'.
Key changes include a stronger focus on risk assessment, reducing redundant information, and distinguishing between guidelines that pertain to humans and animals.
The guidelines also highlight legal requirements and standards pharmacists must follow when compounding.
Pharmacists are reminded not to compound medicines if a suitable commercial alternative exists, if they lack the proper equipment or expertise, or if there's no evidence supporting the safety of the treatment.
Additional resources, including a consumer fact sheet, have been released to help pharmacists inform patients about compounded medicines - CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Sep 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Sep 24
